Computational Methods, based on human biology, are now reaching maturity in the biomedical domain, rendering predictive models of health and disease increasingly relevant to clinical practice by providing a personalized aspect to treatment. Computer based modelling and simulation is well established in the physical sciences and engineering, where the use of high performance computing (HPC) is now routine. CompBioMed is a user-driven Centre of Excellence in Computational Biomedicine, to nurture and promote the uptake and exploitation of high performance computing within the biomedical modelling community. Our user communities come from academia, industry and clinical practice.
Latest CompBioMed News
A list of innovations by the HPC Centres of Excellence, as spotted by the EU innovation radar
The use case assesses the impact of certain COVID-19 drugs on a human heart population
CompBioMed: CT2S – Digital twin application for patient treatment & Bone Strength: In Silico trials solution
One major goal of this use case is to develop an efficient digital twin solution for the estimation of long bone fracture risk in elderly patients.
The objectives of this use case were to demonstrate and assess the strong scaling performance of HemeLB to the largest core counts possible, and to demonstrate the ability of HemeLB to utilise this performance to study flows on human-scale vasculatures.